http://www.yso.fi/onto/yso/p20163 pancreatic cancer
pancreatic cancer
Imaging of tumour microenvironment for the planning of oncological therapies using positron emission tomography
Studies on diagnostic evaluation of pancreatic carcinoma - implications for surgery
Renal cell carcinomas and pancreatic adenocarcinomas produce nidogen in vitro and in vivo
Prognostic value of immunohistochemical expression of p53 inpatients with pancreatic cancer
Novel regulators of pancreatic cancer cell growth and mobility
Novel matrix metalloproteinases in intestinal inflammation and in cancer of the gastrointestinal tract
Prognostic markers in rectal neuroendocrine tumors
Abstract.
Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patietns with pancreatic cancer
Retroperitoneal fibrosis of the pancreatic head mimicking carcinoma of the pancreas
Prediction and management of complications after pancreaticoduodenectomy
Tumour markers in pancreatic cancer
Pancreas in focus
Genome-wide characterization of genetic aberrations in pancreatic cancer
In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer
Sample preservation, tissue autolysis and pancreatic tumours in DNA flow cytometry
The effect of lithium gamma-linolenate therapy of pancreatic cancer on perfusion in liver and pancreatic tissue : [letter to the editor]
Cell adhesion and the deposition of basement membrane in carcinomas
Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane
Endoscopic stenting in gastrointestinal tract
High-field magnetic resonance imaging in the diagnosis of pancreatic diseases : an experimental and clinical study
Cell and molecular biology of pancreatic carcinoma : recent developments in research and experimental therapy
Osteoporosis ; Treatment advances in surgical oncology
MED29 possesses a complex role in pancreatic cancer
Prognostic tumour markers in pancreatic cancer
Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer
Expression and prognostic value of HCGÎ² in digestive tract malignancies
Summary.
Effects of lithium gammalinolenate on the perfusion of liver and pancreatic tissues in pancreatic cancer
Developing genetically engineered oncolytic viruses for cancer gene therapy
Experimental rat pancreatic cancer model and gene therapy
AGR2 : a potential biomarker for pancreatic cancer?
Studies on 68Ga-based agents for PET imaging of cancer and inflammation
Improving oncolytic adenoviral therapies for gastrointestinal cancers and tumor initiating cells
Occupational determinants of pancreatic cancer
Prognostic significance of serum CA 242 in pancreatic cancer : a comparison with CA 19-9
Human trypsinogens in the pancreas and in cancer
Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas
